More on GRI
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.01 |
|
|||
| Open | $2.00 | ||||
| 52 Wk High | $47.03 | ||||
| 52 Wk Low | $37.79 | ||||
| Day High | $2.08 | ||||
| Day Low | $2.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 9,678 | ||||
- GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
- Form 8-K GRI Bio, Inc. For: May 14
- GRI Bio reports Q1 2026 results, advances drug pipeline
- GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Im
- Form SCHEDULE 13G/A GRI Bio, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
- Form 10-Q GRI Bio, Inc. For: Mar 31
- GRI Bio receives UAE patent allowance for NKT cell agonists
- GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
- GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
- Form SCHEDULE 13G/A GRI Bio, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Entities mentioned with GRI
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- S1 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
